Is CDC42 p.Tyr64Ser (c.191A>C) pathogenic?

CDC42 p.Tyr64Ser (c.191A>C) is classified Pathogenic in CDC42 (ClinVar, No assertion criteria, 1 submitter; last evaluated 2021-10-05). AlphaMissense: likely pathogenic (0.9898); Absent from gnomAD v4.1.

How common is CDC42 p.Tyr64Ser (c.191A>C) in the general population?

CDC42 p.Tyr64Ser (c.191A>C) is absent from gnomAD v4.1 (gnomAD).

What do computational predictors say about CDC42 p.Tyr64Ser (c.191A>C)?

AlphaMissense predicts likely pathogenic (score 0.9898) — an in-silico prediction, not a clinical call.

CDC42 p.Tyr64Ser

c.191A>C · rs864309721 · VCV2664644

Pathogenic No assertion criteria

Classification

Pathogenic

ClinVar

Review

No assertion criteria ☆☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely pathogenic

0.9898 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

3/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.9898	likely pathogenic ✓ concordant with ClinVar
REVEL	0.82	moderately pathogenic-leaning
SaProt	LLR -16.78	damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 9.3	GERP 2.4, phastCons 1
Regional constraint	o/e 0.09	constrained · MANE · 8,206 bp · p 1.3e-23 · regional, not allelic
Overall
CADD	28.8	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: CDC42
Protein: p.Tyr64Ser
Coding: c.191A>C
MANE Select: NM_001791
dbSNP: rs864309721
Type: single nucleotide variant
Location: chr1:22086451 (GRCh38)
Gene constraint: LOEUF 0.611 · pLI 0.87 (gnomAD)
Structure: AlphaFold pLDDT 93.30 · 48 PDB
Residue 64: a modified residue (phosphotyrosine; by src); a UniProt-annotated variant site (in tks); an α-helix

Full CDC42 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

CDC42 p.Tyr64Cys Pathogenic/Likely pathogenic ★★ same residue
CDC42 p.Tyr64Asn Likely pathogenic ★ same residue
CDC42 p.Ala159Val Pathogenic ★★ same type
CDC42 p.Arg186Cys Pathogenic ★★ ⚠ same type
CDC42 p.Arg66Gly Pathogenic ★★ same type
CDC42 p.Arg68Gln Pathogenic ★★ same type
CDC42 p.Cys81Phe Likely pathogenic ★★ same type
CDC42 p.Glu171Lys Pathogenic ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdc42-p-tyr64ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown